Therefore, we propose the option of adequate high-dose ureidopenicillin-beta-lactamase inhibitor combination therapy for community-onset bacteraemia with the intent to reduce carbapenem overtreatment especially in low-to moderate-severity infections. The gene discussed is LACTB; the disease is infection.